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Vulvar carcinoma is a rare disease that accounts for 3–5% of all gynecologic malignancies. Breast represents an unusual site of
metastasis and only a few cases are reported. We describe the first case of bilateral metastatic breast carcinoma of vulvar origin, at
an 80-year-old female patient. Six months after treatment of her primary disease, she presented with bilateral metastatic squamous
cell breast carcinoma. Diagnosis was based on clinical, radiological, and histological facts. Breast although rare is another potential
site of metastasis in vulvar cancer and thus mammary gland examination should be considered in the follow-up of these patients.
Differential diagnosis between primary and metastatic lesions is of utmost importance for appropriate management.
1. Introduction
Vulvar cancer represents 3–5% of all gynecological malig-
nancies and 1% of all cancers in females [1]. The disease is
most commonly observed in postmenopausal women aged
65–70 years [2], presenting primarily with localized pruritus,
vulvar mass, bleeding, or pain [3]. Squamous cell carcinoma
is the predominant histological type, accounting for 90%
[4], followed by melanoma, basal cell or Bartholin’s gland
carcinoma, sarcoma, and Paget’s disease [5].
The dissemination pattern of vulvar neoplasms is mostly
lymphogenic and the inguinal and femoral nodes are the
primary sites of regional spread [6]. Direct extension to
adjacent tissues may also occur, while hematogenous spread
to distant organs presents late in the course of vulvar
cancer and is rare in the absence of lymph node metastases
[3].
Metastasis to the breast from vulvar carcinoma is
extremely rare. To our knowledge, only two cases of unilateral
breastmetastasis have been reported [7, 8].We report the first
case of bilateral metastatic breast carcinoma of vulvar origin.
2. Case
An 80-year-old female patient presented in June 2015 with a
4.5 cm vulvar mass, involving the clitoris, the right labium
majus, and the right lateral vaginal wall. Bilateral inguinal
lymph nodes were palpable.The rest of the physical examina-
tion, including breast, was unremarkable. Her previous-year’s
mammogramwas negative. Punch biopsy of the vulvar lesion
was performed and the histological examination revealed a
high grade, invasive vulvar squamous cell carcinoma. The
preoperative evaluation included full blood count, biochem-
ical profile, chest X-ray, and abdominal CT scan. There were
no additional imaging findings and blood tests were within
the normal range.
The patient underwent a radical vulvectomy and bilateral
inguinal lymphadenectomy (triple incision technique). The
histological report revealed an ulcerated tumor, measuring
4.5 × 4 × 3 cm, which showed features of poorly differentiated
invasive squamous cell carcinoma.The surgical margins were
free of disease (0,6 cm). Lymph node histopathology revealed
tumor infiltration of a single ipsilateral lymph node, while
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all the lymph nodes dissected from the left groin showed no
signs of malignancy. Vulvar lesion was, thus, classified stage
IIIA (FIGO staging system) [2]. Patient’s postoperative course
was uncomplicated and she was discharged after twelve days
of hospitalization. Postoperatively, themultidisciplinary team
(MDT) suggested adjuvant radiation therapy and the patient
received a total dose of 45Gy to the groin and pelvis.
Follow-up was performed on an outpatient basis every
three months. On her second visit, there were no signs of
local recurrence. However, a palpable right breast mass at
9 o’clock position was noted. Mammography confirmed its
presence and also revealed a second smaller mass in the
contralateral breast. Fine-needle aspiration (FNAC) of both
lumps was performed and cytological smears were stained
with May-Grunwald-Giemsa and Papanicolaou. Microscopy
revealed keratinized and nonkeratinized malignant squa-
mous cells, with refractile cytoplasm, and individual cells
lacking cohesion. The metastatic workup, including bone
scan and abdominal, pelvic, and chest CT scan, was negative.
Considering patient’s medical history and the characteristic
microscopic pattern of the lesions, diagnosis of metastatic
squamous cell breast carcinoma, arising from the primary
vulvar cancer, was established. Unfortunately, a few days
later, she passed away at home from acute myocardial infarc-
tion.
3. Discussion
Vulvar cancer metastasizes through local spread, the lym-
phatic system, and the bloodstream [6]. The dissemination
pattern is mostly lymphogenic. Lymphatic dye studies, by
Parry-Jones [9], showed that dermal lymphatic network of
the vulva courses to the superficial ipsilateral groin lymph
nodes and then perforates the cribriform fascia to drain
in the deep inguinal (femoral) nodes. Lymphatic drainage
takes place from the lateral sites to the ipsilateral groin
nodes, while drainage from the midline can be bilateral.
At the level of the clitoris some lymph channels may drain
directly to the pelvic lymph nodes. Sentinel lymph node
(SLN) mapping investigates groin lymph node metastasis
and permits less extensive node dissections and recognition
of anatomic variations of the lymphatic channels [10, 11].
Distant metastases may occur either as a result of lymphatic
embolization, in a stepwise fashion, to the pelvic and para-
aortic lymph nodes or as a result of hematogenous spread,
mainly to bones, liver, or lung [2]. They are uncommon in
the initial presentation and encountered more frequently in
the recurrent vulvar cancer, in 8% of patients [12].
The overall recurrence rate, according to Maggino et al.,
is 37.2% [12], while Gonzalez Bosquet et al. reported a rate
of 26.7% [13]. The distribution of recurrences by site, in the
former study, was 53.4% perineal, 18.7% inguinal, 5.7% pelvic,
7.9% distant, and 14.2% multiple. Tumor dimension, lymph
node involvement, and stromal and lymph vascular space
invasion were demonstrated as prognostic factors, predicting
the risk of recurrence [12].
Breast carcinoma is the most common malignant tumor
in females. However, metastatic tumors to the breast are rare
and account for 0.5–1.5% of all breast cancers in clinical series
and 6.6% in autopsy series [14, 15]. The commonest cause
is spread from a contralateral breast carcinoma. Excluding
hematologic malignancies, the most common primary sites
are cutaneous melanoma, bronchogenic carcinoma, gastric
carcinoma, and genitourinary tumors [16]. Among gyneco-
logic cancers, the most frequent metastatic to the breast is
ovarian cancer [17] but sporadic reports pertaining to other
primary gynecologic malignancies, including cancers of the
endometrium, cervix, fallopian tube, and choriocarcinoma,
have been reported [15, 16, 18].
The breast is an exceptional site of metastasis from vulvar
carcinoma. Only two cases have been described in the litera-
ture. In the first case, a 49-year-old woman, surgically treated
for a stage II vulvar squamous cell carcinoma, presented 4
months after the operation with a 4 × 3 cm lump in the
left breast [7]. The histological and immunohistochemical
characteristics of the excisional biopsy specimen, the pres-
ence of human papilloma virus genome, demonstrated by
in situ hybridization, in both vulvar and breast specimens
and the absence of BRST2 confirmed the diagnosis. Surgical
margins of the excisional biopsy were free and no further
treatment was given. The patient remained free of disease
for at least 73 months. In the second case, a 42-year-old
patient, suffering from a stage IVA vulvar squamous cell car-
cinoma, underwent radical vulvectomy and bilateral inguinal
lymphadenectomy followed by external pelvic irradiation, as
inguinal lymph nodes and the inferior surgical border were
infiltrated by the tumor [8]. A recurrence in the left breast
was confirmed by biopsy 3 months later. A modified radical
mastectomy was performed and the patient received 3 cycles
of adjuvant chemotherapy (cyclophosphamide, adriblastine,
and cisplatin). She died at 11months, in the context of cerebral
metastasis.
The recognition of a breast lesion as primary ormetastatic
is crucial since it affects management and prognosis. A
palpable, mobile, painless, well-circumscribed lump, local-
ized at the upper outer quadrant, is the most common
clinical presentation.Mammography usually depictsmultiple
or bilateral lesions, round and smooth, without speculation
[15]. In contrast to primary breast carcinoma, the clinical and
the radiological size of metastatic lesions coincide because of
aminimal desmoplastic reaction around them [18].Diagnosis
is generally achieved histologically by fine-needle aspiration
cytology or open biopsy [19]. FNA can differentiate between
metastatic deposit and primary breast cancer, resulting in
the avoidance of mastectomy and the implementation of the
appropriate adjuvant therapy [20, 21].
In the current case, a typical aspect of squamous cell
carcinoma associated with keratinization was observed in the
breast lesions by FNA. Squamous cells are normally not found
inside the breast. Thus, primary squamous cell carcinoma of
the breast is a very rare tumor accounting for less than 0.1% of
all invasive breast carcinomas and may arise from squamous
metaplasia into an adenocarcinoma [22] or in cysts, abscesses,
chronic inflammation, and fibroadenomas [23]. Its diagnosis
requires the following: the absence of elements other than
malignant epidermoid cells, the independence of the lesion
from adjacent dermal structures, and the exclusion of other
squamous carcinomas in the patient [8, 11, 24]. Consequently,
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our patient’smedical history, in addition to the bilateral breast
mass presentation, amplified the diagnosis of metastatic
breast cancer.
The prognosis of breast metastasis is poor as widespread
tumor dissemination is implied. Most patients die within the
year following the diagnosis. Treatment is palliative, based on
chemotherapy and sometimes comfort surgery [18].
4. Conclusion
This publication is an additional case of vulvar cancer metas-
tasis to a rare location, the breast. Diagnosis was based on
converging clinical, histological, and radiological facts. Dif-
ferential diagnosis between primary and metastatic lesions
is demanded for the appropriate and cost-effective patient
management.
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